An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features

Nancy Adriana Espinoza-Sánchez; Jennifer Enciso; Rosana Pelayo; Ezequiel M. Fuentes-Pananá

doi:10.18632/oncotarget.25465

journal article Jun 01, 2018

An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features

Nancy Adriana Espinoza-Sánchez Jennifer Enciso Rosana Pelayo Ezequiel M. Fuentes-Pananá

Oncotarget Vol. 9 No. 42 pp. 26679-26700 · Impact Journals, LLC

View at Publisher Save 10.18632/oncotarget.25465

Topics

No keywords indexed for this article. Browse by subject →

References

68

[1]

Ferlay "Global estimates of cancer prevalence for 27 sites in the adult population in 2008" Int J Cancer (2013) 10.1002/ijc.27711

[2]

Bray "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012" Int J Cancer (2015) 10.1002/ijc.29210

[3]

Rosen "Modelling breast cancer: one size does not fit all" Nat Rev Cancer (2007) 10.1038/nrc2193

[4]

Witteveen "Gene expression profiling predicts clinical outcome of breast cancer" Nature (2002) 10.1038/415530a

[5]

Esteva "Clinical utility of gene-expression signatures in early stage breast cancer" Nat Rev Clin Oncol (2017) 10.1038/nrclinonc.2017.74

[6]

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Therese Sørlie, Charles M. Perou, Robert Tibshirani et al.

Proceedings of the National Academy of Sciences 2001 10.1073/pnas.191367098

[7]

Fuentes-Panana "Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion" J Oncol (2013) 10.1155/2013/835956

[8]

Microenvironmental regulation of tumor progression and metastasis

Daniela F Quail, Johanna A Joyce

Nature Medicine 2013 10.1038/nm.3394

[9]

Inflammation and cancer: back to Virchow?

Fran Balkwill, Alberto Mantovani

The Lancet 2001 10.1016/s0140-6736(00)04046-0

[10]

Fuentes-Panana "A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness" J Immunol Res (2015) 10.1155/2016/6031486

[11]

Berns "A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer" Cancer Cell (2011) 10.1016/j.ccr.2010.12.021

[12]

Heppner "Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability" Invasion Metastasis (1983)

[13]

Sarkar "Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells" Oncogene (2016) 10.1038/onc.2016.26

[14]

Ellis "Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells" Br J Cancer (2011) 10.1038/bjc.2011.449

[15]

Fuentes-Panana "Evidence of lateral transmission of aggressive features between different types of breast cancer cells" Int J Oncol (2017) 10.3892/ijo.2017.4128

[16]

Boukhali "HER2 expression identifies dynamic functional states within circulating breast cancer cells" Nature (2016) 10.1038/nature19328

[17]

The basics of epithelial-mesenchymal transition

Raghu Kalluri, Robert A. Weinberg

Journal of Clinical Investigation 2009 10.1172/jci39104

[18]

Brisken "The epithelial-mesenchymal transition generates cells with properties of stem cells" Cell (2008) 10.1016/j.cell.2008.03.027

[19]

Knutson "Immune-induced epithelial to mesenchymal transitiongenerates breast cancer stem cells" Cancer Res (2009) 10.1158/0008-5472.can-08-3343

[20]

Kasimir-Bauer "Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients" Breast Cancer Research (2009) 10.1186/bcr2333

[21]

Akhurst "Differentiation plasticity regulated by TGF-beta family proteins in development and disease" Nat Cell Biol (2007) 10.1038/ncb434

[22]

Galluzzi "Trial watch: Immune checkpoint blockers for cancer therapy" Oncoimmunology (2017) 10.1080/2162402x.2017.1373237

[23]

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

Padmanee Sharma, James P. Allison

Cell 2015 10.1016/j.cell.2015.03.030

[24]

Fuentes-Pananá "IL-1β, IL-8 and matrix metalloproteinases -1, -2 and -10 are enriched upon monocyte- breast cancer cell co-cultivation in a Matrigel-based three dimensional system" Frontiers in Immunology (2017) 10.3389/fimmu.2017.00205

[25]

Stein "Reactome pathway analysis to enrich biological discovery in proteomics data sets" Proteomics (2011) 10.1002/pmic.201100066

[26]

Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks

Paul Shannon, Andrew Markiel, Owen Ozier et al.

Genome Research 2003 10.1101/gr.1239303

[27]

MAPK signal pathways in the regulation of cell proliferation in mammalian cells

Wei Zhang, Hui Tu LIU

Cell Research 2002 10.1038/sj.cr.7290105

[28]

NF-kappa B subunit-specific regulation of the interleukin-8 promoter.

C Kunsch, C A Rosen

Molecular and Cellular Biology 1993 10.1128/mcb.13.10.6137

[29]

van de Vijver "The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment" Ann Oncol (2010) 10.1093/annonc/mdp273

[30]

Weaver "Diagnostic concordance among pathologists interpreting breast biopsy specimens" JAMA (2015) 10.1001/jama.2015.1405

[31]

Blanpain "Distinct stem cells contribute to mammary gland development and maintenance" Nature (2011) 10.1038/nature10573

[32]

Blanpain "Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity" Nature (2015) 10.1038/nature14665

[33]

Smalley "BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells" Cell Stem Cell (2010) 10.1016/j.stem.2010.07.010

[34]

Gerstung "Subclonal diversification of primary breast cancer revealed by multiregion sequencing" Nat Med (2015) 10.1038/nm.3886

[35]

Nuciforo "Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer" Cancer Res (2017) 10.1158/0008-5472.can-16-2717

[36]

Heath "HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab" Cancer Res (2013) 10.1158/0008-5472.can-12-3349

[37]

Pantel "Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial" Eur J Cancer (2016) 10.1016/j.ejca.2016.04.024

[38]

Guan "Breast Cancer: Multiple Subtypes within a Tumor?" Trends in Cancer (2017) 10.1016/j.trecan.2017.09.001

[39]

Polyak "Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity" Nature (2014) 10.1038/nature13556

[40]

Gunther "Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers" Nature (2014) 10.1038/nature13187

[41]

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann, Joshua A. Bauer, Xi Chen et al.

Journal of Clinical Investigation 2011 10.1172/jci45014

[42]

Liu "STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer" Theranostics (2017) 10.7150/thno.16827

[43]

Park "The relationship between nuclear factor (NF)-kappaB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment" Sci Rep (2016) 10.1038/srep31804

[44]

Jones "Genomic regulation of invasion by STAT3 in triple negative breast cancer" Oncotarget (2017) 10.18632/oncotarget.14153

[45]

Nakshatri "NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2" Oncogene (2007) 10.1038/sj.onc.1209808

[46]

Monica "NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers" OMICS (2017) 10.1089/omi.2017.0020

[47]

Wang "beta-Catenin and NF-kappaB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer" Cell Death Differ (2015) 10.1038/cdd.2014.145

[48]

Mishra "Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer" Sci Rep (2015) 10.1038/srep10194

[49]

Bertucci "Defining the Molecular Biology of Inflammatory Breast Cancer" Seminars in Oncology (2008) 10.1053/j.seminoncol.2007.11.015

[50]

Iglehart "NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis" Proc Natl Acad Sci U S A (2004) 10.1073/pnas.0403621101

Showing 50 of 68 references

Metrics

14

Citations

68

References

Details

Published: Jun 01, 2018
Vol/Issue: 9(42)
Pages: 26679-26700

Authors

N

Nancy Adriana Espinoza-Sánchez

Programa de Doctorado en Ciencias Biomédicas, Facultad de Medicina, Universidad Nacional Autónoma de México, C.P. 04510, Ciudad de México, México; Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México Federico Gómez, C.P. 06720, Ciudad de México, México

J

Jennifer Enciso

Programa de Posgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, C.P. 04510, Ciudad de México, México; Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, C.P. 04510, Ciudad de México, México; Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, C.P. 74360, Metepec, Puebla, México

R

Rosana Pelayo

Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, C.P. 74360, Metepec, Puebla, México

E

Ezequiel M. Fuentes-Pananá

Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México Federico Gómez, C.P. 06720, Ciudad de México, México

Cite This Article

Nancy Adriana Espinoza-Sánchez, Jennifer Enciso, Rosana Pelayo, et al. (2018). An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget, 9(42), 26679-26700. https://doi.org/10.18632/oncotarget.25465

An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features

You May Also Like